Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall discussions show a mix of cautious support and skepticism, with posts referencing the publication's findings that the evidence for increased thyroid cancer risk is inconclusive, exemplified by phrases like 'no significant risk' and 'pending further evidence.' The tone fluctuates between tentative reassurance and cautious questioning, which indicates moderate engagement and interest without strong emotional investment.
Many posts agree that the meta-analysis suggests no strong link between GLP-1 use and thyroid cancer, reflecting cautious consensus.
Overall interest appears neutral; some discussions mention potential risks but do not delve deeply into details.
Posts demonstrate moderate engagement by referencing specific studies, contrasting findings, and questioning data sources.
The discussions could influence perceptions of GLP-1 safety but generally do not suggest a revolutionary shift in clinical practice.
https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials (301 trials 94063 participants):
In trial data does not describe an association between GLP1 use and thyroid cancer; however, a French national database suggests an increase in the hazard for thyroid CA with GLP1 use. Which data are we to believe? [RCTs] https://t.co/JaPsNqYTJV [Observational]
Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/mAff6AM7Qh
@TaupeAvenger @hyperplanes None of the metastudies I’ve seen suggest a statistically significant risk https://t.co/qRuN6OGVre
Dock sågs inte samma samband i Hu et al metaanalys från 2022. Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X, Liu J. Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials. Front Endocrinol Lausanne
New Research: Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials: The association between glucagon-like peptide-1 (GLP-1) receptor agonists and the risk of various… https://t.co/SqbZbSCZrt #Endocrinology #Endo
This video discusses the potential risks associated with GLP-1 receptor agonists, particularly the connection to thyroid cancer. It examines findings from studies related to the increased risk of thyroid cancer…
Research says People taking #semaglutide drugs may also have an increased risk of developing #thyroidcancer . Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomised Controlled Trials - PMC #thyroiddisease #health https://t.co/6xdwmqUaUI
@medicoclasto @pochienfadado @chungopailot de ensayos clínicos en 2022 que no demostró aumento de riesgo. Y hay sigue la cosa, pendiente de evolución. Enlaces: https://t.co/Xc55FxbTO4 https://t.co/EZ01ZXbEYK
Dock sågs inte samma samband i Hu et al metaanalys från 2022. Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X, Liu J. Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials. Front Endocrinol Lausanne
RT @MichaelAlbertMD: In trial data does not describe an association between GLP1 use and thyroid cancer; however, a French national databas…
RT @MichaelAlbertMD: In trial data does not describe an association between GLP1 use and thyroid cancer; however, a French national databas…
In trial data does not describe an association between GLP1 use and thyroid cancer; however, a French national database suggests an increase in the hazard for thyroid CA with GLP1 use. Which data are we to believe? [RCTs] https://t.co/JaPsNqYTJV [Observational]
Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/Aw6mkA54kW
@AbudBakri My understanding is that the thyroid cancer risk has been seen in rodents, but not necessarily humans. But, yes on pancreatitis. https://t.co/ehwBQtbXIx(RR%201.17%2C%2095
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
So, MTC increase seems to be a myth... Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/7pVNbXOH3v
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials (301 trials 94063 participants):
Frontiers | Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/oFgyT6ggzk
RT @florencarral: Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https…
RT @florencarral: Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https…
Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/mAff6AM7Qh
@TaupeAvenger @hyperplanes None of the metastudies I’ve seen suggest a statistically significant risk https://t.co/qRuN6OGVre
New Research: Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials: The association between glucagon-like peptide-1 (GLP-1) receptor agonists and the risk of various… https://t.co/SqbZbSCZrt #Endocrinology #Endo
CM
MM
FC
AD
C
FE
NW
MV
NM
M
RS
AM
LG
L
MB
JA
DB
RR
L
BD
ND
JM
RV
DS
JY
MB
DP
CP
DJ
KB
EO
S
MV
MT
DE
JF
TH
MC
U
CM
RF
RT
EC
M
LP
G
FZ
AC
AF
S